The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hyperthermia Treatment for Cancer Market Research Report 2025
Synopsis
The global Hyperthermia Treatment for Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Hyperthermia Treatment for Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hyperthermia Treatment for Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hyperthermia Treatment for Cancer include Andromedic Sri, Celsius42 GmbH, Huahang, Pyrexar Medical, Perseon Medical, Omron Corporation and Sjn AG Yamamoto Vinita, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hyperthermia Treatment for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperthermia Treatment for Cancer.
Report Scope
The Hyperthermia Treatment for Cancer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hyperthermia Treatment for Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hyperthermia Treatment for Cancer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Andromedic Sri
Celsius42 GmbH
Huahang
Pyrexar Medical
Perseon Medical
Omron Corporation
Sjn AG Yamamoto Vinita
Segment by Type
Microwave Hyperthermia Device
Ultrasound Hyperthermia Device
Infrared Therapy Device
Short-Wave Therapy Device
Segment by Application
Hospitals
Clinics
Research Institutes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hyperthermia Treatment for Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hyperthermia Treatment for Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Hyperthermia Treatment for Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Hyperthermia Treatment for Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hyperthermia Treatment for Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hyperthermia Treatment for Cancer include Andromedic Sri, Celsius42 GmbH, Huahang, Pyrexar Medical, Perseon Medical, Omron Corporation and Sjn AG Yamamoto Vinita, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hyperthermia Treatment for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperthermia Treatment for Cancer.
Report Scope
The Hyperthermia Treatment for Cancer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hyperthermia Treatment for Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hyperthermia Treatment for Cancer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Andromedic Sri
Celsius42 GmbH
Huahang
Pyrexar Medical
Perseon Medical
Omron Corporation
Sjn AG Yamamoto Vinita
Segment by Type
Microwave Hyperthermia Device
Ultrasound Hyperthermia Device
Infrared Therapy Device
Short-Wave Therapy Device
Segment by Application
Hospitals
Clinics
Research Institutes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hyperthermia Treatment for Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hyperthermia Treatment for Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hyperthermia Treatment for Cancer Market Overview
1.1 Product Overview and Scope of Hyperthermia Treatment for Cancer
1.2 Hyperthermia Treatment for Cancer Segment by Type
1.2.1 Global Hyperthermia Treatment for Cancer Market Value Comparison by Type (2024-2030)
1.2.2 Microwave Hyperthermia Device
1.2.3 Ultrasound Hyperthermia Device
1.2.4 Infrared Therapy Device
1.2.5 Short-Wave Therapy Device
1.3 Hyperthermia Treatment for Cancer Segment by Application
1.3.1 Global Hyperthermia Treatment for Cancer Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 Global Hyperthermia Treatment for Cancer Market Size Estimates and Forecasts
1.4.1 Global Hyperthermia Treatment for Cancer Revenue 2019-2030
1.4.2 Global Hyperthermia Treatment for Cancer Sales 2019-2030
1.4.3 Global Hyperthermia Treatment for Cancer Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hyperthermia Treatment for Cancer Market Competition by Manufacturers
2.1 Global Hyperthermia Treatment for Cancer Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hyperthermia Treatment for Cancer Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hyperthermia Treatment for Cancer Average Price by Manufacturers (2019-2024)
2.4 Global Hyperthermia Treatment for Cancer Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hyperthermia Treatment for Cancer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hyperthermia Treatment for Cancer, Product Type & Application
2.7 Hyperthermia Treatment for Cancer Market Competitive Situation and Trends
2.7.1 Hyperthermia Treatment for Cancer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hyperthermia Treatment for Cancer Players Market Share by Revenue
2.7.3 Global Hyperthermia Treatment for Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hyperthermia Treatment for Cancer Retrospective Market Scenario by Region
3.1 Global Hyperthermia Treatment for Cancer Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hyperthermia Treatment for Cancer Global Hyperthermia Treatment for Cancer Sales by Region: 2019-2030
3.2.1 Global Hyperthermia Treatment for Cancer Sales by Region: 2019-2024
3.2.2 Global Hyperthermia Treatment for Cancer Sales by Region: 2025-2030
3.3 Global Hyperthermia Treatment for Cancer Global Hyperthermia Treatment for Cancer Revenue by Region: 2019-2030
3.3.1 Global Hyperthermia Treatment for Cancer Revenue by Region: 2019-2024
3.3.2 Global Hyperthermia Treatment for Cancer Revenue by Region: 2025-2030
3.4 North America Hyperthermia Treatment for Cancer Market Facts & Figures by Country
3.4.1 North America Hyperthermia Treatment for Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hyperthermia Treatment for Cancer Sales by Country (2019-2030)
3.4.3 North America Hyperthermia Treatment for Cancer Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hyperthermia Treatment for Cancer Market Facts & Figures by Country
3.5.1 Europe Hyperthermia Treatment for Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hyperthermia Treatment for Cancer Sales by Country (2019-2030)
3.5.3 Europe Hyperthermia Treatment for Cancer Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hyperthermia Treatment for Cancer Market Facts & Figures by Country
3.6.1 Asia Pacific Hyperthermia Treatment for Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hyperthermia Treatment for Cancer Sales by Country (2019-2030)
3.6.3 Asia Pacific Hyperthermia Treatment for Cancer Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hyperthermia Treatment for Cancer Market Facts & Figures by Country
3.7.1 Latin America Hyperthermia Treatment for Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hyperthermia Treatment for Cancer Sales by Country (2019-2030)
3.7.3 Latin America Hyperthermia Treatment for Cancer Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hyperthermia Treatment for Cancer Market Facts & Figures by Country
3.8.1 Middle East and Africa Hyperthermia Treatment for Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hyperthermia Treatment for Cancer Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hyperthermia Treatment for Cancer Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hyperthermia Treatment for Cancer Sales by Type (2019-2030)
4.1.1 Global Hyperthermia Treatment for Cancer Sales by Type (2019-2024)
4.1.2 Global Hyperthermia Treatment for Cancer Sales by Type (2025-2030)
4.1.3 Global Hyperthermia Treatment for Cancer Sales Market Share by Type (2019-2030)
4.2 Global Hyperthermia Treatment for Cancer Revenue by Type (2019-2030)
4.2.1 Global Hyperthermia Treatment for Cancer Revenue by Type (2019-2024)
4.2.2 Global Hyperthermia Treatment for Cancer Revenue by Type (2025-2030)
4.2.3 Global Hyperthermia Treatment for Cancer Revenue Market Share by Type (2019-2030)
4.3 Global Hyperthermia Treatment for Cancer Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hyperthermia Treatment for Cancer Sales by Application (2019-2030)
5.1.1 Global Hyperthermia Treatment for Cancer Sales by Application (2019-2024)
5.1.2 Global Hyperthermia Treatment for Cancer Sales by Application (2025-2030)
5.1.3 Global Hyperthermia Treatment for Cancer Sales Market Share by Application (2019-2030)
5.2 Global Hyperthermia Treatment for Cancer Revenue by Application (2019-2030)
5.2.1 Global Hyperthermia Treatment for Cancer Revenue by Application (2019-2024)
5.2.2 Global Hyperthermia Treatment for Cancer Revenue by Application (2025-2030)
5.2.3 Global Hyperthermia Treatment for Cancer Revenue Market Share by Application (2019-2030)
5.3 Global Hyperthermia Treatment for Cancer Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Andromedic Sri
6.1.1 Andromedic Sri Corporation Information
6.1.2 Andromedic Sri Description and Business Overview
6.1.3 Andromedic Sri Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Andromedic Sri Hyperthermia Treatment for Cancer Product Portfolio
6.1.5 Andromedic Sri Recent Developments/Updates
6.2 Celsius42 GmbH
6.2.1 Celsius42 GmbH Corporation Information
6.2.2 Celsius42 GmbH Description and Business Overview
6.2.3 Celsius42 GmbH Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Celsius42 GmbH Hyperthermia Treatment for Cancer Product Portfolio
6.2.5 Celsius42 GmbH Recent Developments/Updates
6.3 Huahang
6.3.1 Huahang Corporation Information
6.3.2 Huahang Description and Business Overview
6.3.3 Huahang Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Huahang Hyperthermia Treatment for Cancer Product Portfolio
6.3.5 Huahang Recent Developments/Updates
6.4 Pyrexar Medical
6.4.1 Pyrexar Medical Corporation Information
6.4.2 Pyrexar Medical Description and Business Overview
6.4.3 Pyrexar Medical Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pyrexar Medical Hyperthermia Treatment for Cancer Product Portfolio
6.4.5 Pyrexar Medical Recent Developments/Updates
6.5 Perseon Medical
6.5.1 Perseon Medical Corporation Information
6.5.2 Perseon Medical Description and Business Overview
6.5.3 Perseon Medical Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Perseon Medical Hyperthermia Treatment for Cancer Product Portfolio
6.5.5 Perseon Medical Recent Developments/Updates
6.6 Omron Corporation
6.6.1 Omron Corporation Corporation Information
6.6.2 Omron Corporation Description and Business Overview
6.6.3 Omron Corporation Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Omron Corporation Hyperthermia Treatment for Cancer Product Portfolio
6.6.5 Omron Corporation Recent Developments/Updates
6.7 Sjn AG Yamamoto Vinita
6.6.1 Sjn AG Yamamoto Vinita Corporation Information
6.6.2 Sjn AG Yamamoto Vinita Description and Business Overview
6.6.3 Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Product Portfolio
6.7.5 Sjn AG Yamamoto Vinita Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hyperthermia Treatment for Cancer Industry Chain Analysis
7.2 Hyperthermia Treatment for Cancer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hyperthermia Treatment for Cancer Production Mode & Process
7.4 Hyperthermia Treatment for Cancer Sales and Marketing
7.4.1 Hyperthermia Treatment for Cancer Sales Channels
7.4.2 Hyperthermia Treatment for Cancer Distributors
7.5 Hyperthermia Treatment for Cancer Customers
8 Hyperthermia Treatment for Cancer Market Dynamics
8.1 Hyperthermia Treatment for Cancer Industry Trends
8.2 Hyperthermia Treatment for Cancer Market Drivers
8.3 Hyperthermia Treatment for Cancer Market Challenges
8.4 Hyperthermia Treatment for Cancer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
